logo
ProjectActive

Di'An Diagnostics

The status, timeline and source of this project. A free account opens every field.

Source: IFC Project Disclosures

The proposed investment is a long-term corporate loan of up to US$150 million to Di’An Diagnostics Group Co. Ltd., (“Di’An Diagnostics”, “Di’An”, or the “company”), one of the largest third-party diagnostic services and product providers in China with ~40 laboratories across China serving more than 20,000 medical institutions, and which is publicly listed on the Shenzhen Stock Exchange (300244). U

Status
Prospective
Sector
Hospital, Manufacturing (Industrial)
Location
China
Updated
19 Nov 2026
Source
IFC Project Disclosures

ConstructChat

Ask ConstructChat about Di'An Diagnostics

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Di'An Diagnostics” is an infrastructure initiative in the Hospital sector, located in China. Taiyo aggregates data on it from IFC Project Disclosures.

Participants

Not available for this record.

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

The proposed investment is a long-term corporate loan of up to US$150 million to Di’An Diagnostics Group Co. Ltd., (“Di’An Diagnostics”, “Di’An”, or the “company”), one of the largest third-party diagnostic services and product providers in China with ~40 laboratories across China serving more than 20,000 medical institutions, and which is publicly listed on the Shenzhen Stock Exchange (300244). Under the proposed use of proceeds, Di’An will: (i) add up to five new diagnostic centers to its independent clinical laboratory (ICL) network including associated cold chain warehouses; (ii) expand existing ICLs including upgrading of equipment; (iii) expand its self-developed In Vitro Diagnostic (IVD) production capacity, (iv) expand its research and development operations; and (v) build advanced IT infrastructure and data analytics functions over the next five years (together, the “Project”). Project locations will mostly be in the major provincial capitals of China. The additional IVD production capacity will mainly focus on advanced diagnostic fields of application, such as mass spectrometry, molecular diagnostics, and micronutrient diagnostics.Di’An Diagnostics Group Co., Ltd. (http://www.dazd.cn/) is located in Hangzhou, Zhejiang, China. Dian Diagnostics Group Co., Ltd. has 9,300 total employees across all of its locations and generated $1.65 billion in sales (USD) by the end of 2020. There are 147 companies in the Dian Diagnostics Group Co., Ltd. corporate family. Most Di’An Diagnostics laboratories and manufacturing facilities are located within industrial parks, with limited exposure to local communities as such parks are typically set up at considerable distances from local residences and sensitive E&S receptor areas.

Original sector

other

Location

Country

China

Source

Source

IFC Project Disclosures

URL

More Details

Record type

Project

Sector

Hospital, Manufacturing (Industrial)

Article published date

2026-09-09

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project